Barely Significant
← all excerpts

P2Y12 Inhibitor or Aspirin Monotherapy for Chronic Coronary Disease: A Nationwide Cohort Study.

Cardiovasc Ther · 2025 · PMC12721736 · PMID 41438591

Europe PMCDOI
1
hedged sentence
0.0820
closest p · 1.6× alpha
0.0820
boldest claim

The sentences

showed a trendp = 0.082so close (0.05 < p ≤ 0.1)
In secondary analyses, P2Y12 inhibitors showed a trend toward reduced major bleeding (HR: 0.86; 95% CI: 0.72–1.02; p = 0.082) and a significant reduction in major gastrointestinal bleeding (HR: 0.79; 95% CI: 0.63–0.97; p = 0.027).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.